Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817646 | 1.00 | ZDHHC7 (0.56) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL820645 | 0.93 | CA2 (0.53) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL486955 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL16832270 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8991586 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2944230 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2293185 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8584856 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL7543085 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8816706 | 0.87 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2011-11-10 | — | — | US | disclosed |
| CN-102066350-A | Method for obtaining cinatrins C3 and C1 | CONSEJO SUPERIOR INVESTIGACION | 2011-05-18 | — | — | CN | disclosed |
| EP-2287157-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | Consejo Superior de Investigaciones Cientificas (ES) | 2011-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | C3AR1, CPA3, CYP21A2 | ZDHHC7 1313/4885CA2 556/4885CA1 392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.